Skip to main content
SpringerLink
Log in

Inhibition of protein kinase B by palmitate in the insulin signaling of HepG2 cells and the preventive effect of arachidonic acid on insulin resistance

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

Elevated plasma levels of free fatty acids (FFAs) may contribute to insulin resistance (IR) that is characteristic of type 2 diabetes mellitus. In this study, we investigated the effects of two fatty acids, palmitate (PA) and arachidonic acid (AA) on glycogenesis under insulin signaling in HepG2cells, a transformed hepatic carcinoma cell line. In the presence of 200 μmol of palmitate, insulin (10−7 mol/L) stimulation of glycogenesis was inhibited, as evidenced by increased glucose in the medium and decreased intracellular glycogen. Wortmannin (WM), a specific inhibitor of PI3K, dramatically decreased the amount of intracellular glycogen in cells without PA incubation. However, glycogen in PA treated cells was not significantly changed by WM, indicating that PA may also act on PI3K. Interestingly, AA restored the effects of WM inhibition on glycogenesis in PA cells. Western blot analysis demonstrated that PA in the absence of WM increased phosphorylated glycogen synthase (inactive form of GS) and decreased phosphorylated protein kinase B (active form of PKB), causing a reduction of intracellular glycogen. AA, however, reversed the effects of PA on GS and PKB. Furthermore, inhibition of protein kinase C (PKC) by a specific inhibitor chelerythrine chloride (CC) abolished the inhibitory effect of PA on glycogen synthesis by decreasing phosphorylated GS and increasing phosphorylated PKB. However, the effect of CC in the presence of PA disappeared when AA was also present.

Our results suggest that there is a disruption of the insulin signaling pathway between PKB and GS when the cells were exposed to PA, contributing to IR. PA may also interrupt the PKC signaling pathway. In contrast, AA could rescue glycogenesis impaired by PA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes, 2005, 54(7): 1942–1948

    Article  CAS  PubMed  Google Scholar 

  2. Bastard J P, Maachi M, Lagathu C, Kim M J, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 2006, 17(1): 4–12

    CAS  PubMed  Google Scholar 

  3. Raubenheimer P J, Nyirenda M J, Walker B R. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes, 2006, 55(7): 2015–2020

    Article  CAS  PubMed  Google Scholar 

  4. Armoni M, Harel C, Bar-Yoseph F, Milo S, Karnieli E. Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem, 2005, 14,280(41): 34786–34795

    Article  Google Scholar 

  5. Koo S H, Montminy M. Fatty acids and insulin resistance: A perfect storm. Mol Cell, 2006, 21(4): 449–450

    Article  CAS  PubMed  Google Scholar 

  6. Takahashi A, Shimano H, Nakagawa Y, Yamamoto T, Motomura K, Matsuzaka T, Sone H, Suzuki H, Toyoshima H, Yamada N. Transgenic mice overexpressing SREBP-1a under the control of the PEPCK promoter exhibit insulin resistance, but not diabetes. Biochim Biophys Acta, 2005, 1740(3): 427–433

    Article  CAS  PubMed  Google Scholar 

  7. Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB. Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA. Diabetologia, 2006, 49(9): 2144–2152

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Storgaard H, Jensen C B, Bjornholm M, Song X M, Madsbad S, Zierath J R, Vaag A A. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab, 2004, 89(3): 1301–1311

    Article  CAS  PubMed  Google Scholar 

  9. Chavez J A, Holland W L, Bar J, Sandhoff K, Summers S A. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem, 2005, 20,280(20): 20148–20153

    Article  Google Scholar 

  10. Ginsberg H N, Zhang Y L, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res, 2005, 36(3): 232–240

    Article  CAS  PubMed  Google Scholar 

  11. Rask-Madsen C, King G L. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol, 2005, 25(3): 487–496

    Article  CAS  PubMed  Google Scholar 

  12. Klover P J, Mooney R A. Hepatocytes: Critical for glucose homeostasis. Int J Biochem Cell Biol, 2004, 36(5): 753–758

    Article  CAS  PubMed  Google Scholar 

  13. Taniguchi C M, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest, 2005, 115(3): 718–727

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Gual P, Le Marchand-Brustel Y, Tanti J F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie, 2005, 87(1): 99–109

    Article  CAS  PubMed  Google Scholar 

  15. Feldstein A E, Werneburg N W, Canbay A, Guicciardi M E, Bronk S F, Rydzewski R, Burgart L J, Gores G J. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology, 2004, 40(1): 185–194

    Article  CAS  PubMed  Google Scholar 

  16. Yun M R, Lee J Y, Park H S, Heo H J, Park J Y, Bae S S, Hong K W, Sung S M, Kim C D. Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway. Pharmacol Res, 2006, 54(2): 97–102

    Article  CAS  PubMed  Google Scholar 

  17. Wang X L, Zhang L, Youker K, Zhang M X, Wang J, LeMaire S A, Coselli J S, Shen Y H. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes, 2006, 55(8): 2301–2310

    Article  CAS  PubMed  Google Scholar 

  18. Mook S, Halkes Cj C, Bilecen S, Cabezas M C. In vivo regulation of plasma free fatty acids in insulin resistance. Metabolism, 2004, 53(9): 1197–1201

    Article  CAS  PubMed  Google Scholar 

  19. Tiikkainen M, Hakkinen A M, Korsheninnikova E, Nyman T, Makimattila S, Yki-Jarvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes, 2004, 53(8): 2169–2176

    Article  CAS  PubMed  Google Scholar 

  20. Powell D J, Turban S, Gray A, Hajduch E, Hundal H S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J, 2004, 382(Pt 2): 619–629

    CAS  PubMed  Google Scholar 

  21. Gupta D, Khandelwal R L. Modulation of insulin effects on phosphorylation of protein kinase B and glycogen synthesis by tumor necrosis factor-alpha in HepG2 cells. Biochim Biophys Acta, 2004, 1671(1–3): 51–58

    Article  CAS  PubMed  Google Scholar 

  22. Jessen N, Djurhuus C B, Jorgensen J O, Jensen L S, Moller N, Lund S, Schmitz O. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am J Physiol Endocrinol Metab, 2005, 288(1): E194–E199

    Article  CAS  PubMed  Google Scholar 

  23. Au C S, Wagner A, Chong T, Qiu W, Sparks J D, Adeli K. Insulin regulates hepatic apolipoprotein B production independent of the mass or activity of Akt1/PKBalpha. Metabolism, 2004, 53(2):228–35

    Article  CAS  PubMed  Google Scholar 

  24. Gaster M, Beck-Nielsen H. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim Biophys Acta, 2006, 1761(1): 100–110

    Article  CAS  PubMed  Google Scholar 

  25. Bailey C J. Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones. Diabetes Obes Metab, 2005, 7(6): 675–691

    Article  CAS  PubMed  Google Scholar 

  26. Bajotto G, Murakami T, Nagasaki M, Qin B, Matsuo Y, Maeda K, Ohashi M, Oshida Y, Sato Y, Shimomura Y. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: Induction by elevated levels of free fatty acids. Metabolism, 2006, 55(3):317–323

    Article  CAS  PubMed  Google Scholar 

  27. Du K, Herzig S, Kulkarni R N, Montminy M. TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science, 2003, 300: 1574–1577

    Article  CAS  PubMed  Google Scholar 

  28. Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetes — pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab, 2006, 2(6): 335–348

    Article  CAS  PubMed  Google Scholar 

  29. Kim J K, Fillmore J J, Sunshine M J, Albrecht B, Higashimori T, Kim D W, Liu Z X, Soos T J, Cline G W, O’Brien W R, Littman D R, Shulman G I. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest, 2004, 114(6):823–827

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Dickinson R, Adler A, Gagne G, Iyengar R, Zhao G, Marsh K, Kym P, Jung P, Camp H S, Frevert E. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab, 2006, 3(6): 403–416

    Article  CAS  PubMed  Google Scholar 

  31. Louet J F, LeMay C, Mauvais-Jarvis F. Anti-diabetic actions of estrogen: Insight from human and genetic mouse models. Curr Atheroscler Rep, 2004, 6(3): 180–185

    Article  PubMed  Google Scholar 

  32. Min Y, Lowy C, Ghebremeskel K, Thomas B, Offley-Shore B, Crawford M. Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: A potential marker of fetal insulin resistance. Am J Clin Nutr, 2005, 82(6): 1162–1168

    CAS  PubMed  Google Scholar 

  33. Delarue J, LeFoll C, Corporeau C, Lucas D. N-3 long chain polyunsaturated fatty acids: A nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev, 2004, 44(3): 289–299

    Article  CAS  PubMed  Google Scholar 

  34. Verlengia R, Gorjao R, Kanunfre C C, Bordin S, de Lima T M, Curi R. Effect of arachidonic acid on proliferation, cytokines production and pleiotropic genes expression in Jurkat cells—A comparison with oleic acid. Life Sciences, 2003, 73(23):2939–2951

    Article  CAS  PubMed  Google Scholar 

  35. Song M K, Hwang I K, Rosenthal M J, Harris D M, Yamaguchi D T, Yip I, Go V L. Antidiabetic action of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki Rats. Metabolism, 2003, 52(1): 7–12

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Xia Yanzhi MS

  2. Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Wan Xuedong MS, Duan Qiuhong PhD, He Shansu BS & Wang Ximing BS

Authors
  1. Xia Yanzhi MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wan Xuedong MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Duan Qiuhong PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. He Shansu BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wang Ximing BS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wang Ximing BS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, Y., Wan, X., Duan, Q. et al. Inhibition of protein kinase B by palmitate in the insulin signaling of HepG2 cells and the preventive effect of arachidonic acid on insulin resistance. Front. Med. China 1, 200–206 (2007). https://doi.org/10.1007/s11684-007-0038-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-007-0038-y

Keywords

Search

Navigation